See-and-treat outpatient hysteroscopy: an analysis of 1109 examinations  Cagri Gulumser, Nitish Narvekar, Mamta Pathak, Elsa Palmer, Sarah Parker, Ertan Saridogan  Reproductive BioMedicine Online  Volume 20, Issue 3, Pages 423-429 (March 2010) DOI: 10.1016/j.rbmo.2009.11.024 Copyright © 2009 Terms and Conditions

Figure 1 Outcome tree for subjects with a regular endometrial cavity on hysteroscopy examination. The incidence of pathology and cancer in the group with normal or thin endometrium was low (hyperplasia: 4/403, 1.0%; adenocarcinoma: 1/403, 0.25%) compared with group with thick (hyperplasia, 2/39, 5.1%; adenocarcinoma, 3/39, 7.7%) or suspected malignancy (adenocarcinoma: 2/6, 33.3%). *=endometrial biopsy showed adenocarcinoma in one patient and hyperplasia in another. Reproductive BioMedicine Online 2010 20, 423-429DOI: (10.1016/j.rbmo.2009.11.024) Copyright © 2009 Terms and Conditions

Figure 2 Outcome tree for subjects with an irregular endometrial cavity on hysteroscopy examination. Of these, 328/609 (53.4%) were amenable to a see-and-treat approach and 190/609 (39.2%) of subjects underwent hysteroscopy treatment under general anaesthesia, 24 women with polyps and 56 women with fibroids decided not have treatment. Further treatment was not indicated in 11 women with Müllerian anomalies. The prevalence of associated endometrial pathology was small (hyperplasia: 5/609, 0.8%; carcinoma: 5/609, 0.8%). *=endometrial biopsy showed adenocarcinoma in one patient and hyperplasia in another. Reproductive BioMedicine Online 2010 20, 423-429DOI: (10.1016/j.rbmo.2009.11.024) Copyright © 2009 Terms and Conditions